Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The number of sprays per nostril and frequency of administration may vary, necessitating adherence to the specific guidelines
Dihexa is a research-stage, investigational peptide, so it is discussed for general interest rather than as a treatment for any cognitive condition
Subcutaneous injections exceeding 0.5mL per site reduce absorption efficiency due to depot formation
Discontinuation in trials: retatrutide trial discontinuation due to adverse events was 6-10% across the higher-dose arms meaningful but lower than the dose-related side-effect profile would suggest, which indicates most participants tolerated the protocol
All current evidence comes from preclinical animal and cellular studies, meaning its efficacy and safety in people remain unproven
Very stable peptide
US$ 24.55
US$ 20.03
US$ 24.18
US$ 27.48
